Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Efficacy of Eslicarbazepine acetate in Pediatric Refractory Partial Epilepsy
NCT02170064Phase 2Completed
- Sponsor
- BIAL
- Start
- Jun 2005
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eslicarbazepine acetate in partial epilepsy, sponsored by BIAL. Started Jun 2005; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT02170064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170064.